CV Sciences (CVSI) Enterprise Value (2010 - 2026)
CV Sciences' (CVSI) quarterly Enterprise Value came in at -$309000.0 in Q1 2026, up 61.95% year-on-year from -$190804.6 in Q1 2025, and down 11.15% quarter-over-quarter from -$278000.0 in Q4 2025.
CV Sciences (CVSI) Enterprise Value (2010 - 2026) Analysis & Trends
CV Sciences has disclosed Enterprise Value across 17 years of filings, most recently posting -$309000.0 for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$309000.0, up 61.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$309000.0 (up 61.95% YoY), and the FY2025 annual result was -$278000.0, up 38.77% from the prior year.
- Enterprise Value came in at -$309000.0 for Q1 2026 at CV Sciences, down from -$278000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$278000.0 in Q4 2025 to a low of -$2.4 million in Q1 2022.
- The 5-year median for Enterprise Value is -$812000.0 (2025), against an average of -$935588.2.
- Across the five-year window, Enterprise Value tumbled 115.55% in 2023 and soared 71.78% in 2024, its largest moves.
- CV Sciences' Enterprise Value stood at -$611000.0 in 2022, then sank by 115.55% to -$1.3 million in 2023, then surged by 65.53% to -$454000.0 in 2024, then jumped by 38.77% to -$278000.0 in 2025, then slipped by 11.15% to -$309000.0 in 2026.
- The last three Enterprise Value figures came in at -$309000.0 (Q1 2026), -$278000.0 (Q4 2025), and -$381000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -309,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Jun 30, 2025 | -886,000.00 |
| Mar 31, 2025 | -812,000.00 |
| Dec 31, 2024 | -454,000.00 |
| Sep 30, 2024 | -979,000.00 |
| Jun 30, 2024 | -477,000.00 |
| Mar 31, 2024 | -662,000.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -1.69 Mn |
| Mar 31, 2023 | -714,000.00 |
| Dec 31, 2022 | -611,000.00 |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -2.44 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Jun 30, 2021 | -2.96 Mn |
| Mar 31, 2021 | -5.67 Mn |